NL1044088A - Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food (Dietary Supplement) - Google Patents
Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food (Dietary Supplement) Download PDFInfo
- Publication number
- NL1044088A NL1044088A NL1044088A NL1044088A NL1044088A NL 1044088 A NL1044088 A NL 1044088A NL 1044088 A NL1044088 A NL 1044088A NL 1044088 A NL1044088 A NL 1044088A NL 1044088 A NL1044088 A NL 1044088A
- Authority
- NL
- Netherlands
- Prior art keywords
- nmn
- resveratrol
- magnesium
- mood
- metabolism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Magnesium (Mg) (1) is very important for normal energy utilization of the cell, and normal maintenance of the nerve and muscle. Rhodiola extract (2) has proven effect on fatigue relief. In a preclinical and clinical studies, beside other effects, nicotine amide mononucleotide (NMN) (3) has been associated with properties such as mood and sleep improvement and depression reduction, white resveratrol has a large number of overall health benefits. Healthy food supplement, containing a combination of Magnesium (1), Rhodiola extract (2), nicotinamide mononucleotide (NMN) (3) and resveratrol (4) is expected to have positive effects on mood and should help with sleep improvement, and fatigue relief.
Description
i Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food {Dietary Supplement)
Discussion & While positive effects of Magnesium and Rhodiola extract have been known for centuries, NMN and resveratrol are getting in the focus in the last years, As this is a novel combination, below are presented effects of each of these products individually.
Magnesium (Mg) (1) Magnesium is the fourth most abundant mineral in the human body, One of magnesiimt's main roles is acting as a cofactor or helper molecule in the blochamical reactions comtingously performed by enzymes. Magnesium is a mineral that supports hundreds of chemical reactions in your body. However, many people get less than they need. Magnesium plays a critical role m brain function and mood. and low levels are linked to an increased risk of depression, There may be a Bak between depression and magnesium deficiency. Supplementing with it can reduce symptoms of depression in some people.
Magnesium is safe and widely available. Rbaodivla extract (2) Rhodiola has long been kaown as an adaptogen, a natural substance that increases your bodys resistance to stress in non-specific ways, Consaming adaptogens during stresstud times is thought to help you handle stressful situations better, Stress, anxiety and inadequate sleep are just a few factors that can contribute to fatigue, which can cause feelings of physical and mental tiredness. Due to its adaptogenic properties, rhodiola is thought to help alleviate fatigue. One four-week study in 60 people with stress-related fatigue looked at its effects on quality of life and symptoms of fatigue, depression and attention, Participants received either $76 mg of rhodiola or a placebo pill daily. It found that thodinla had a positive effect on fatigue levels and attention compared to the placebo, In a similar study, 100 people with chronic fatigue symptoms received 400 mg of rhodiola every day for eight weeks, They experienced significant improvements in stress symptoms, fatigue, quality of {ife, mood and concentration {8 Trusted Source). These improvements were observed after only ong week of treatment and contineed to improve through the final wesk of the study.
NMN (Nicotinamide Monenucleotide} Molecule (3) NMN naturally exists in avocadoes, tomatoes, cucumber, cabbages, broccoli, and raw beef. In the laboratory, it is available as nicotinamide mononucleotide bull powder, In the human body, NMN is the principal source of energy within the cells. As we age, cellalar energy decreases due to the low levels of nicotinamide mononucleotide and subsequent reduction of NAD. Administering NMN will reverse the process and compensate for the defieit. NMN exists in both alpha (1) and beta (5) forms, However, B-NMN is the most active form, This bioactive nucleotide is an intermediate in the biosynthesis of nicotinamide adenine dinaclectide or NAD. FDA recommends that any human being needs approximately 560 mg of NMN per day.
Human Clinical Trials with NIN
~ There are 113 ongoing clinical trials in humans that are investigating NAD precursors INMN, NR and Niacin}, majority of them are not completed and only few have results published. The most important study in humans was a study in Japanese man, that showed that the single oral administration of NMN up to 500 mg was safe and well-tolerated in healthy men without causing any significant deleterious effects. It has demonstrated that the oral. ~ administration of NMN is feasible and could be a therapeutic strategy to replenish cellular NAD™ levels to mitigate aging-related functional disorders in humans. - Trials in humans with results are: An international collaborative team including researchers from Keio University in Tokyo and Washington University School of Medicine in St. Louis is running a phase | study of NMN in Japan, Clinical trials examining the safety and efficacy of NMN are also currently being run at Washington University, investigating the effect on insulin sensitivity, endothelial function, lipids, body and liver fat and markers of cardiovascular and metabolic health.
© Arandomizeg, double-blind, three-arm crossover pharmacokinetic study in 12 human subjects showed that NR raises NAD+ by as much as 2.7-fold in human blood with a single oral dose of 1000 mg. Researchers at the University of Washington have completed a clinical trial with 140 participants showing that orally administered NR gives a dose o dependent increase in NAD+ from 250-1000 mg/d plateauing at a 2-fold increase in NAD+ at day nine.
o Researchers have also reported positive effects of NR on vascular endothelial function in healthy middle-aged and older adults, with further investigations of motor and cognitive changes to come.
-Recently, researchers have found that a resveratrol analog called pterostilbene combined with NR seemed to help ALS/Lou Gehrig's patients.
-Most recently, a placebo-controlled study assessing 500 mg of NR, taken twice daily by 70- to 80-year olds, showed increases in NAD+ in blood (but not muscle.) inflammation fell and, unexpectedly, mitochondrial activity did too.
-Muitiple other studies are now underway assessing the effects of NR on muscle mitochondrial function, cognition, immune function, kidney function, traumatic brain injury, brown fat activity, lipid accumulation, energy metabolism, cardiovascular risk, body composition, and acetylcarnitine levels, Clinical trials results should be available in the new few years. What we can claim with certainly at this moment, based on clinical research data is that NMN is safe and welt toleratad in healthy men and that it is able to successfully replenish cellular NAD+ levels, And we know that decline in NAD levels is associated with aging. NAN Animal Studies Animal studies are confirming that the pharmacological activities of MIN include its rede in 18 - cetidlar biochemical functions, cardio protection, diabetes, Alzheimer's disease, and complications associated with obesity. The recent groundbreaking discovery of anti- ageing activities of this chemical molety has added a valuable essence in the research involving this molecule, Studies confirmed that manipulation of mitochondrial NAD levels by NMN resulls in - metabolic changes that pralect mitochondria against reactive oxygen species and gxcessive fragmentation, offering therapeutic approaches for pathophysiologic stress conditions, Resveratrol (4) Resveratrol is a nutrient fund abundantly in the skin of red grapes that is known to have robust antioxidant and anti-inflaspmatory properties.
The efficacy, safety, and pharmacokinetics of Resveratrol have been documented in over 244 clinical trials, with an additional 27 clinical trials currently ongoing.
Resveratrol has various biochemical and physiological effects such as antiinflammatory, antioxidative, antiprofiferative and chemo-praventive effects. Recent studies have shown iis positive effects especially on cardiovascular diseases, cancer, type 2 diabetes and neurological disorders.
Resveratrol is reported to potentially improve the therapeutic outcome in patients suffering from diabetes mellitus, obesity, colorectal cancer, breast cancer, multiple myeloma, metabolic syndrome, hypertension, Alzheimer's disease, stroke, cardiovascular diseases, kidney diseases, inflammatory diseases, and rhinopharyngitis.
it was also proven that it mimics caloric restriction, which has numerous positive effects, Resveratrol is reported to be safe al doses up to 5 g/d, when used either alone or as a combination therapy.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1043753 | 2020-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL1044088A true NL1044088A (en) | 2022-04-04 |
NL1044088B1 NL1044088B1 (en) | 2022-07-13 |
Family
ID=78463854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL1044088A NL1044088B1 (en) | 2020-08-12 | 2021-07-06 | Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food (Dietary Supplement) |
Country Status (1)
Country | Link |
---|---|
NL (1) | NL1044088B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110123510A1 (en) * | 2009-09-24 | 2011-05-26 | Washington University | Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis |
EP3513796A1 (en) * | 2016-09-13 | 2019-07-24 | Megumi Tanaka | Sleep disorder improvement agent and method for improving sleep disorders |
-
2021
- 2021-07-06 NL NL1044088A patent/NL1044088B1/en active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110123510A1 (en) * | 2009-09-24 | 2011-05-26 | Washington University | Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis |
EP3513796A1 (en) * | 2016-09-13 | 2019-07-24 | Megumi Tanaka | Sleep disorder improvement agent and method for improving sleep disorders |
Non-Patent Citations (3)
Title |
---|
DARBINYAN V ET AL: "Rhodiola rosea in stress induced fatigue- A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty", MEDICINAL & AROMATIC PLANTS ABSTRACTS, SCIENTIFIC PUBLISHERS, SCIENTIFIC PUBLISHERS, NEW DELHI - INDIA, vol. 23, no. 6, 1 December 2001 (2001-12-01), XP018015666, ISSN: 0250-4367 * |
KELLY G S: "Rhodiola rosea: a possible plant adaptogen", ALTERNATIVE MEDICINE REVIEW, 1 June 2001 (2001-06-01), United States, pages 293 - 302, XP055905126, Retrieved from the Internet <URL:http://nutradvance.pt/wp-content/uploads/2016/04/Ref84.293.pdf> [retrieved on 20220324] * |
LIMANAQI FIONA ET AL: "Potential Antidepressant Effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea", ANTIOXIDANTS, 12 March 2020 (2020-03-12), Switzerland, pages 234, XP055905117, Retrieved from the Internet <URL:https://www.mdpi.com/2076-3921/9/3/234> [retrieved on 20220324], DOI: 10.3390/antiox9030234 * |
Also Published As
Publication number | Publication date |
---|---|
NL1044088B1 (en) | 2022-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ari et al. | Exogenous ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk rats | |
Ibrahimpasic | Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment | |
Rossi et al. | The potential of β-hydroxy-β-methylbutyrate as a new strategy for the management of sarcopenia and sarcopenic obesity | |
HOLLANDER et al. | Relationship between diuretic and antihypertensive effects of chlorothiazide and mercurial diuretics | |
Canguven et al. | Vitamin D and male erectile function: an updated review | |
Husain et al. | Weight loss in narcolepsy patients treated with sodium oxybate | |
US20090286750A1 (en) | Use of ribose in lessening the clinical symptoms of aberrant firing of neurons | |
Morita et al. | Clinical evaluation of changes in biomarkers by oral intake of NMN. | |
RU2657824C1 (en) | Method of biocorrection of premature aging of organism and skin | |
JP2011241209A (en) | Bdnf production accelerator having ganglioside or derivative thereof as active ingredient, and medical product, food and drink and feed containing the bdnf production accelerator | |
AU2016311131A1 (en) | Mineral compositions for stimulating the carbohydrate metabolism | |
NL1044088B1 (en) | Combination of Magnesium, Rhodiola Extract, Nicotinamide Mononucleotide (NMN) and Resveratrol as Healthy Functional Food (Dietary Supplement) | |
RU2568584C2 (en) | Method and preparation for increasing adaptive abilities of athlete's organism in training process period | |
ITRM20130655A1 (en) | PRODUCT BASED ON AN ASSOCIATION OF GLUCOMANNAN AND INOSITLE | |
NL1044087B1 (en) | Combination of Vitamin C, red ginseng, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement)) | |
US20100323031A1 (en) | Synergistic combination to enhance blood glucose and insulin metabolism | |
NL1044089B1 (en) | Combination of Vitamin C, red ginseng, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement)) | |
NL1044086B1 (en) | Combination of Zn, red ginseng, saw palmetto fruit extracts, nicotinamide mononucleotide (NMN) and resveratrol as a food supplement | |
NL1044090B1 (en) | Combination of vitamin B6, ginseng, green tea extract, Ganoderma lucidum, black cohosh root, nicotinamide mononucleotide (NMN) and resveratrol as a healthy functional food (food supplement) | |
JP4355967B2 (en) | Pharmaceutical composition | |
Nowak et al. | Resveratrol impacts health in patients with diabetes mellitus and other metabolic conditions | |
KR20050121324A (en) | Compositions for the urinary dysfuction and edema containing decursin and/or decursinol angelate, or angelica extract containing decursin and/or decursinol angelate | |
US10383904B2 (en) | Composition for improving health and quality of life of women containing ginseng berry extract | |
RU2553374C1 (en) | Method for increasing body adaptability under thermal stress | |
WO2015092538A1 (en) | Use of extract or fraction of ophiocordyceps in manufacture of medicament for treatment of sleeping disorder |